• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

LRRK2 突变携带者的亚临床征象。

Subclinical signs in LRRK2 mutation carriers.

机构信息

Department of Neurology, St. Olav's University Hospital, Trondheim, Norway.

出版信息

Parkinsonism Relat Disord. 2011 Aug;17(7):528-32. doi: 10.1016/j.parkreldis.2011.04.014. Epub 2011 Jun 8.

DOI:10.1016/j.parkreldis.2011.04.014
PMID:21641848
Abstract

BACKGROUND

Several non-motor features have been reported to precede the motor signs of Parkinson's disease (PD) by several years. However, the time of onset of non-motor and motor symptoms is still debated. Healthy individuals carrying a PD-related mutation are candidates for studying the earliest disease signs.

OBJECTIVES

To describe clinically healthy family members of PD patients carrying a LRRK2 mutation (LRRK2-PD).

METHODS

A total of 47 family members of LRRK2-PD patients were included in the present study and were screened for the p.G2019S and p.N1437H substitutions in the LRRK2 gene. A standardized case report form was filled out in each case, including general medical evaluation, neurological examination with UPDRS, an olfaction test, mood, sleep and cognitive questionnaires.

RESULTS

Thirty-two study participants were positive, and 15 were negative for a LRRK2 mutation. Higher UPDRS motor scores, more frequent reports of urinary problems, and fewer hours of sleep were found in mutation carriers compared to non-carriers. The mutation carriers with UPDRS ≥8 were all aged over 50 years, had shorter overall sleeping hours, more frequent urinary and constipation problems, higher mood scores and body mass index. Deterioration of olfaction was not detected in either group.

CONCLUSION

Healthy LRRK2 mutation carriers presented subclinical parkinsonian motor and non-motor signs in the apparent absence of olfactory loss. Longitudinal studies will determine whether these changes precede alterations detectable by neuroimaging.

摘要

背景

已有报道称,几种非运动症状在帕金森病(PD)的运动症状出现前几年就已经出现。然而,非运动和运动症状的发病时间仍存在争议。携带 PD 相关突变的健康个体是研究最早疾病迹象的候选者。

目的

描述携带 LRRK2 突变(LRRK2-PD)的 PD 患者的健康家族成员。

方法

本研究共纳入 47 名 LRRK2-PD 患者的家族成员,并对 LRRK2 基因中的 p.G2019S 和 p.N1437H 取代进行筛查。对每位患者填写标准化病例报告表,包括一般医学评估、UPDRS 神经检查、嗅觉测试、情绪、睡眠和认知问卷。

结果

32 名研究参与者的 LRRK2 基因突变检测结果为阳性,15 名参与者的 LRRK2 基因突变检测结果为阴性。与非携带者相比,突变携带者的 UPDRS 运动评分更高、更频繁地报告出现尿失禁问题、睡眠时间更短。UPDRS≥8 的突变携带者均为 50 岁以上,总睡眠时间较短,尿失禁和便秘问题更频繁,情绪评分和体重指数更高。两组患者的嗅觉恶化均未检测到。

结论

在明显没有嗅觉丧失的情况下,健康的 LRRK2 突变携带者出现亚临床帕金森病的运动和非运动症状。纵向研究将确定这些变化是否早于神经影像学可检测到的改变。

相似文献

1
Subclinical signs in LRRK2 mutation carriers.LRRK2 突变携带者的亚临床征象。
Parkinsonism Relat Disord. 2011 Aug;17(7):528-32. doi: 10.1016/j.parkreldis.2011.04.014. Epub 2011 Jun 8.
2
Olfactory dysfunction in LRRK2 G2019S mutation carriers.LRRK2 G2019S 突变携带者的嗅觉功能障碍。
Neurology. 2011 Jul 26;77(4):319-24. doi: 10.1212/WNL.0b013e318227041c. Epub 2011 Jul 13.
3
Motor phenotype of LRRK2-associated Parkinson's disease: a Tunisian longitudinal study.LRRK2 相关性帕金森病的运动表型:一项突尼斯纵向研究。
Mov Disord. 2015 Feb;30(2):253-8. doi: 10.1002/mds.26097. Epub 2014 Dec 9.
4
Motor and non-motor features of Parkinson's disease in LRRK2 G2019S carriers versus matched controls.LRRK2 G2019S 携带者与匹配对照者帕金森病的运动和非运动特征。
J Neurol Sci. 2018 May 15;388:203-207. doi: 10.1016/j.jns.2018.03.025. Epub 2018 Mar 17.
5
Olfactory dysfunction in sporadic Parkinson's Disease and LRRK2 carriers.散发型帕金森病和 LRRK2 携带者的嗅觉功能障碍。
Acta Neurol Scand. 2014 May;129(5):300-6. doi: 10.1111/ane.12172. Epub 2013 Aug 13.
6
Clinical and brain imaging characteristics in leucine-rich repeat kinase 2-associated PD and asymptomatic mutation carriers.富亮氨酸重复激酶 2 相关帕金森病及无症状突变携带者的临床和脑影像特征。
Mov Disord. 2011 Nov;26(13):2335-42. doi: 10.1002/mds.23991. Epub 2011 Oct 11.
7
Neuropsychological performance in LRRK2 G2019S carriers with Parkinson's disease.携带LRRK2 G2019S基因的帕金森病患者的神经心理学表现。
Parkinsonism Relat Disord. 2015 Feb;21(2):106-10. doi: 10.1016/j.parkreldis.2014.09.033. Epub 2014 Nov 20.
8
Dyskinesias in patients with Parkinson's disease: effect of the leucine-rich repeat kinase 2 (LRRK2) G2019S mutation.帕金森病患者的运动障碍:富含亮氨酸重复激酶 2(LRRK2)G2019S 突变的影响。
Parkinsonism Relat Disord. 2012 Nov;18(9):1039-41. doi: 10.1016/j.parkreldis.2012.05.014. Epub 2012 Jun 13.
9
Clustering of motor and nonmotor traits in leucine-rich repeat kinase 2 G2019S Parkinson's disease nonparkinsonian relatives: A multicenter family study.LRRK2 G2019S 帕金森病非帕金森亲属的运动和非运动特征聚类:一项多中心家族研究。
Mov Disord. 2018 Jul;33(6):960-965. doi: 10.1002/mds.27272. Epub 2018 Apr 17.
10
Fall risk and gait in Parkinson's disease: the role of the LRRK2 G2019S mutation.帕金森病患者的跌倒风险和步态:LRRK2 G2019S 突变的作用。
Mov Disord. 2013 Oct;28(12):1683-90. doi: 10.1002/mds.25587. Epub 2013 Oct 7.

引用本文的文献

1
p.L1795F LRRK2 variant is a common cause of Parkinson's disease in Central Europe.p.L1795F LRRK2变异是中欧帕金森病的常见病因。
Res Sq. 2024 May 29:rs.3.rs-4378197. doi: 10.21203/rs.3.rs-4378197/v1.
2
Molecular mechanisms defining penetrance of -associated Parkinson's disease.定义与帕金森病相关的外显率的分子机制。
Med Genet. 2022 Aug 12;34(2):103-116. doi: 10.1515/medgen-2022-2127. eCollection 2022 Jun.
3
Genetic heterogeneity on sleep disorders in Parkinson's disease: a systematic review and meta-analysis.帕金森病睡眠障碍的遗传异质性:系统评价和荟萃分析。
Transl Neurodegener. 2022 Apr 8;11(1):21. doi: 10.1186/s40035-022-00294-1.
4
Profiling Non-motor Symptoms in Monogenic Parkinson's Disease.单基因帕金森病非运动症状的剖析
Front Aging Neurosci. 2020 Oct 30;12:591183. doi: 10.3389/fnagi.2020.591183. eCollection 2020.
5
Olfactory Dysfunction in Familial and Sporadic Parkinson's Disease.家族性和散发性帕金森病中的嗅觉功能障碍
Front Neurol. 2020 May 29;11:447. doi: 10.3389/fneur.2020.00447. eCollection 2020.
6
CSF total and oligomeric α-Synuclein along with TNF-α as risk biomarkers for Parkinson's disease: a study in LRRK2 mutation carriers.脑脊液总α-突触核蛋白和寡聚体α-突触核蛋白以及 TNF-α 作为帕金森病的风险生物标志物:LRRK2 突变携带者的研究。
Transl Neurodegener. 2020 May 6;9(1):15. doi: 10.1186/s40035-020-00192-4.
7
Sleep Disorders in Parkinsonian and Nonparkinsonian LRRK2 Mutation Carriers.帕金森病和非帕金森病LRRK2突变携带者的睡眠障碍
PLoS One. 2015 Jul 15;10(7):e0132368. doi: 10.1371/journal.pone.0132368. eCollection 2015.
8
Elevated levels of cerebrospinal fluid α-synuclein oligomers in healthy asymptomatic LRRK2 mutation carriers.健康无症状LRRK2突变携带者脑脊液中α-突触核蛋白寡聚体水平升高。
Front Aging Neurosci. 2014 Sep 25;6:248. doi: 10.3389/fnagi.2014.00248. eCollection 2014.
9
Effect of dual-task interference on the hand flexibility of patients with Parkinson's disease carrying the leucine-rich repeat kinase 2 gene mutation.双重任务干扰对携带富含亮氨酸重复激酶2基因突变的帕金森病患者手部灵活性的影响。
Exp Ther Med. 2013 Dec;6(6):1469-1474. doi: 10.3892/etm.2013.1352. Epub 2013 Oct 18.
10
Non-motor and motor features in LRRK2 transgenic mice.LRRK2 转基因小鼠的非运动和运动特征。
PLoS One. 2013 Jul 30;8(7):e70249. doi: 10.1371/journal.pone.0070249. Print 2013.